SecBot SecBot

School Access to Naloxone Act of 2023

S. 2946 Sen. Jeff Merkley (D-OR) In committee
Bill text PDF
  1. Introduced Sep 27
  2. Committee Sep 27
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Sep 27, 2023Next: Senate vote
1127d ago Sep 27, 2023: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 4 filings
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

School Access to Naloxone Act of 2023

Full summary3 paragraphs

This bill authorizes grants for expanding access to drugs or devices to treat opioid overdoses (e.g., naloxone) in elementary and secondary schools.

The Department of Health and Human Services may award the grants to states, Indian tribes, and localities. To receive a grant, recipients must certify that schools in their jurisdictions will stock the drugs and devices and have trained staff on premises during operating hours to administer them.

Additionally, the attorney general of the recipient's state must certify that trained staff are covered by state civil liability protections for individuals who administer aid in an emergency (commonly known as Good Samaritan laws).

Library of Congress summary, Sep 27, 2023

Summary versions
  • Introduced in SenateSep 27, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.